Company intelligence / Profile preview

TRiCares

Munich, Bavaria, Germanytricares.com ↗

Ownership: Private
Development stage: Phase 1

Overview

TRiCares has developed Topaz, a minimally invasive transfemoral tricuspid heart valve replacement system for patients with severe tricuspid regurgitation who are not candidates for open-heart surgery. The company recently secured FDA Investigational Device Exemption to begin an Early Feasibility Study in the US and plans to initiate a pivotal trial in Europe. Additional development includes new valve sizes and next-generation delivery systems. No commercial or late-stage clinical results have been published yet.

Therapeutic areas: Cardiovascular
Modalities: Device (Transcatheter heart valve replacement system)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Topaz

Phase 1

Indications: Tricuspid regurgitation

Partnerships

None specifically disclosed; supported by leading life science venture capital firms and strategic investors.

Beyond the preview

Go deeper on TRiCares.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRiCares.

Explore the full profile